Sign in

Trial site

Spectrum Neuroscience and Treatment Institute

New York, New York 10021-4157, United StatesNot linked to an institution yet
  • 2running trials
  • 2closed trials

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions
Phase
  • Phase 22 trials
  • Phase 32 trials
Status
  • Active, not recruiting2 trials
  • Completed2 trials
Lead sponsor
  • Definium Therapeutics US, Inc.2 trials
  • COMPASS Pathways1 trial
  • Vertero Therapeutics1 trial

Running trials

Closed trials

Site data: ClinicalTrials.govUpdated 15 Nov 2026

Spectrum Neuroscience and Treatment Institute: trial site – Frontlight Research